Arcus Biosciences, Inc.
NYSE · Healthcare · Pharmaceutical Preparations · Hayward, CA
RCUS chart
What traders are saying about $RCUS
Latest postsArcus Biosciences, Inc. news
- Arcus Biosciences Announces New Employment Inducement Grants
Yahoo Finance ·
- Three new hires get options and stock awards tied to 5,350 shares
Stock Titan ·
- How Investors May Respond To Arcus Biosciences (RCUS) $250 Million Share Sale
Yahoo Finance ·
- Arcus Biosciences (RCUS) Stock Looks Stretched As Casdatifan Trial Data Impresses
Yahoo Finance ·
- Arcus Biosciences Closes $269.7 Million Stock Offering
TradingView ·
- Is Arcus Biosciences (RCUS) Too Expensive After New Trial Data?
Simply Wall Street ·
- Watkins Advises Arcus Biosciences on US$250 Million Public Offering of Common Stock
Latham & Watkins LLP ·
- Arcus Biosciences (RCUS) Shares Drop 6% Pre-Market on $250M Publ
GuruFocus ·
- Arcus Biosciences prices $250M public offering at $17.50 per share
TradingView ·
- Why is Arcus Biosciences stock sliding today? By Investing.com
Investing.com Nigeria ·
- Arcus Biosciences Prices $250 Million Common Stock Offering; Shares Down Pre-Bell
marketscreener.com ·
- Arcus Biosciences reports $694M cash for pipeline advancement through pivotal trials
The Clinical Trial Vanguard ·
Arcus Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $33.0M | $51.0M | $37.0M | $38.0M |
| Net income | -$353.0M | -$283.0M | -$307.0M | -$267.0M |
| Diluted EPS | $-3.29 | $-3.14 | $-4.15 | $-3.71 |
| Total assets (year end) | $1.14B | $1.15B | $1.09B | $1.34B |
| Cash and equivalents (year end) | $222.0M | $150.0M | $127.0M | $206.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Arcus Biosciences, Inc.
- Ticker
- RCUS (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Hayward, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1724521
Frequently asked questions
What exchange is Arcus Biosciences, Inc. listed on?
Arcus Biosciences, Inc. trades on the NYSE under the ticker symbol RCUS.
What industry is Arcus Biosciences, Inc. in?
Arcus Biosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Arcus Biosciences, Inc. headquartered?
Arcus Biosciences, Inc.'s business address on file with the SEC is in Hayward, CA.
When does Arcus Biosciences, Inc.'s fiscal year end?
Arcus Biosciences, Inc.'s fiscal year ends on December 31.
How much revenue did Arcus Biosciences, Inc. report?
Arcus Biosciences, Inc. reported $33.0M in revenue for calendar year 2025, according to its SEC filings.